Disclosed is an adhesive skin patch containing medication other than bisoprolol. Specifically disclosed is an adhesive skin patch which is suppressed in the occurrence of oozing or squeezing-out of the components of the adhesive layer of the adhesive skin patch from the exposed section of the adhesive layer and in the reduction of a medication content due to the oozing of the medication from the adhesive layer, which occur while the adhesive skin patch is stored. Each of a support, a peeling liner, and the adhesive layer and the whole of the adhesive skin patch have a rectangular planar shape, projecting sections being respectively provided on the support-side surface at the corners of the adhesive skin patch. Moreover, it is possible to provide the center section and the circumferential section in the adhesive skin patch and to provide projecting sections at the corners of the rectangular shape of the center section. Furthermore, it is possible to provide, between two or more adjacent projecting sections, raised connecting sections where the adhesive skin patch is thinner than in the projecting sections. If providing a back split section in the peeling liner, the back split section is made to avoid passing through the projecting sections.Se describe un parche adhesivo cutáneo que contiene un medicamento distinto al bisoprolol. Se describe específicamente un parche adhesivo cutáneo que se retira al ocurrir la expulsión o compresión de los componentes de la capa adhesiva del parche adhesivo cutáneo desde la sección expuesta de la capa adhesiva y que también se retira al reducirse un contenido de medicamento debido a la expulsión del medicamento de la capa adhesiva, que ocurre mientras se almacena el parche adhesivo cutáneo. Cada uno de un soporte, un revestimiento desprendible, y la capa adhesiva y la totalidad del parche adhesivo cutáneo, tienen una forma plana rectangular, cuyas secciones de proyección se proporcionan respectivamente en la superficie del lado de so
